https://www.selleckchem.com/pr....oducts/bibo-3304-tri
Abstract Despite significant gains in survival rates for pediatric patients and adolescents/young adults (AYA) with chronic illness, patients in this vulnerable age group are also at an increased risk for developing one or more adverse effects related to their disease, treatment, or maladaptive health behaviors. Maladaptive health behaviors ultimately increase the risk for developing adverse effects, including increased rates of morbidity and mortality, impaired physical functioning, increased fatigue, obesity, increa
Like
Comment
Share
